Eric Valeur

598 total citations
5 papers, 150 citations indexed

About

Eric Valeur is a scholar working on Endocrinology, Diabetes and Metabolism, Cell Biology and Molecular Biology. According to data from OpenAlex, Eric Valeur has authored 5 papers receiving a total of 150 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Endocrinology, Diabetes and Metabolism, 3 papers in Cell Biology and 2 papers in Molecular Biology. Recurrent topics in Eric Valeur's work include Hormonal Regulation and Hypertension (3 papers), Aldose Reductase and Taurine (2 papers) and Viral Infections and Immunology Research (1 paper). Eric Valeur is often cited by papers focused on Hormonal Regulation and Hypertension (3 papers), Aldose Reductase and Taurine (2 papers) and Viral Infections and Immunology Research (1 paper). Eric Valeur collaborates with scholars based in Switzerland, Germany and France. Eric Valeur's co-authors include Roger J. Griffin, Bernard T. Golding, Christiane Riedinger, Ian R. Hardcastle, M.E.M. Noble, Jane Endicott, James M. McDonnell, Lynette A. Smyth, Anna Watson and Marc Lecomte and has published in prestigious journals such as Journal of the American Chemical Society and Bioorganic & Medicinal Chemistry Letters.

In The Last Decade

Eric Valeur

5 papers receiving 149 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eric Valeur Switzerland	5	103	45	19	17	17	5	150
Jill Nunez Switzerland	6	114 1.1×	82 1.8×	14 0.7×	12 0.7×	21 1.2×	6	201
Chester Yuan United States	5	50 0.5×	54 1.2×	21 1.1×	31 1.8×	40 2.4×	7	155
Kristin Goldberg United Kingdom	10	93 0.9×	71 1.6×	19 1.0×	19 1.1×	22 1.3×	12	165
Lara S. Kallander United States	7	99 1.0×	111 2.5×	18 0.9×	16 0.9×	7 0.4×	9	207
Liangqin Guo United States	7	82 0.8×	71 1.6×	33 1.7×	41 2.4×	9 0.5×	7	189
Danette A. Dudley United States	7	195 1.9×	81 1.8×	24 1.3×	6 0.4×	7 0.4×	7	284
Pratik Devasthale United States	8	87 0.8×	63 1.4×	17 0.9×	17 1.0×	35 2.1×	11	159
Anita J. Kempf-Grote United States	6	110 1.1×	108 2.4×	9 0.5×	44 2.6×	37 2.2×	6	244
Josef R. Bencsik United States	7	109 1.1×	97 2.2×	16 0.8×	9 0.5×	5 0.3×	8	174
Karen A. Evans United States	9	201 2.0×	77 1.7×	22 1.2×	34 2.0×	17 1.0×	16	301

Countries citing papers authored by Eric Valeur

Since Specialization

Citations

This map shows the geographic impact of Eric Valeur's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Valeur with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Valeur more than expected).

Fields of papers citing papers by Eric Valeur

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric Valeur. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Valeur. The network helps show where Eric Valeur may publish in the future.

Co-authorship network of co-authors of Eric Valeur

This figure shows the co-authorship network connecting the top 25 collaborators of Eric Valeur. A scholar is included among the top collaborators of Eric Valeur based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric Valeur. Eric Valeur is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Namoto, Kenji, Finton Sirockin, Holger Sellner, et al.. (2018). Structure-based design and synthesis of macrocyclic human rhinovirus 3C protease inhibitors. Bioorganic & Medicinal Chemistry Letters. 28(5). 906–909. 11 indexed citations

2.

Valeur, Eric, Djordje Müsil, L Doaré, et al.. (2012). Structure-based design of 7-azaindole-pyrrolidine amides as inhibitors of 11β-hydroxysteroid dehydrogenase type I. Bioorganic & Medicinal Chemistry Letters. 22(18). 5909–5914. 11 indexed citations

3.

Roche, Didier, Caroline Leriche, L Doaré, et al.. (2009). Discovery and structure-guided drug design of inhibitors of 11β-hydroxysteroid-dehydrogenase type I based on a spiro-carboxamide scaffold. Bioorganic & Medicinal Chemistry Letters. 19(13). 3682–3685. 21 indexed citations

4.

Roche, Didier, Caroline Leriche, L Doaré, et al.. (2009). Discovery and structure–activity relationships of pentanedioic acid diamides as potent inhibitors of 11β-hydroxysteroid dehydrogenase type I. Bioorganic & Medicinal Chemistry Letters. 19(10). 2674–2678. 13 indexed citations

5.

Riedinger, Christiane, Jane Endicott, Lynette A. Smyth, et al.. (2008). Analysis of Chemical Shift Changes Reveals the Binding Modes of Isoindolinone Inhibitors of the MDM2-p53 Interaction. Journal of the American Chemical Society. 130(47). 16038–16044. 94 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact